• Primary Goal Not Met in Anthera Pharmaceuticals, Inc. (ANTH)'s Lupus Drug Study More...
• Shire plc (SHPGY) Gaucher Drugs Beats Sanofi (France) (SAN.PA) Med in Trial More...
• Access Pharmaceuticals (ACCP) Announces Positive Data From MuGard Phase 4 Clinical Trial In Oral Mucositis At MASCC/ISOO 2012 Symposium More...
• Merrimack Pharmaceuticals Inc. Announces Expansion of Phase 3 NAPOLI-1 Study of MM-398 in Late Stage Pancreatic Cancer More...
• Health Canada Warns Hospira, Inc. (HSP) Over Paclitaxel Batches More...
• FDA Grants Priority Review to Bayer HealthCare (BAY), Onyx Pharmaceuticals, Inc. (ONXX)'s Regorafenib More...
• Gilead Sciences, Inc. (GILD) Seeks FDA Approval for HIV Drug More...
• Shionogi, Inc. Says FDA is Reviewing Dry Vagina Drug More...
• Sanofi Pasteur (SASY.PA) Gets Positive Opinion on Hexaxim More...
• Sprinting, Not Jogging, Sheds More Harmful Belly Fat, University of New South Wales Study More...
• Standing at Work All Day While Pregnant Linked to Smaller Babies, Erasmus University Medical Center Study More...
• Menopausal Women Could "Work Out" Their Hot Flashes, Penn State University Study More...
• Common Household Chemical Can Increase Child's Risk for Eczema, Harvard School of Public Health Study More...
• GenSpera G-202 Data in Peer-Reviewed Journal Supports Prodrug Strategy More...
• OxyContin Maker, Purdue Pharma L.P., Guards Exclusivity More...
• Humanetics Announces Alzheimer's Disease Patent Issuance More...
• Mylan Inc. (MYL) Confirms First-to-File Patent Challenge Relating to Pristiq® Tablets More...
• Skinvisible, Inc. (SKVI)'s Hand Sanitizer Kills "Super Bug" MRSA and E. coli For Up to 4 Hours More...
• Mylan Inc. (MYL) Launches Thiamine Hydrochloride Injection More...
• Humanetics Announces Alzheimer's Disease Patent Issuance More...
• Mylan Inc. (MYL) Confirms First-to-File Patent Challenge Relating to Pristiq® Tablets More...
• Skinvisible, Inc. (SKVI)'s Hand Sanitizer Kills "Super Bug" MRSA and E. coli For Up to 4 Hours More...
• Mylan Inc. (MYL) Launches Thiamine Hydrochloride Injection More...
|
0 comments